Featured Research

from universities, journals, and other organizations

Cataract surgery saves $123.4 billion in costs, delivers 4,567% return to society

Date:
November 15, 2013
Source:
American Academy of Ophthalmology (AAO)
Summary:
Cataract surgeries performed over one year eventually save $123.4 billion over 13 years and delivers a 4,567 percent financial return on investment to society according to the results of a cost-utility study. Researchers say that the results prove that healthcare interventions create substantial economic wealth.

Cataract surgeries performed over one year eventually save $123.4 billion over 13 years and delivers a 4,567 percent financial return on investment to society according to the results of a cost-utility study, published online today in the Academy's official journal, Ophthalmology, and will be presented on Nov. 17 at the world's largest ophthalmic conference, the American Academy of Ophthalmology's 117th Annual Meeting, in New Orleans. Researchers say that the results prove that healthcare interventions create substantial economic wealth.

Cataract, which affects approximately 24.5 million Americans, is a condition in which the eye's lens becomes cloudy and can lead to blindness if not treated through surgery. Cataract surgery is the most common, major ophthalmic surgical procedure. Researchers from the Center for Value-Based Medicineฎ used data from the National Study of Cataract Outcomes. They measured both the direct and indirect costs associated with vision loss due to cataract and compared these costs to the value of cataract surgery in 2012. They also compared their findings to similar studies that were also conducted using the National Study of Cataract Outcomes in both 2000 and 1985.

The majority of the $123.4 billion savings are in patient cost savings and Medicare savings, which accounted for 39.4 percent 29.5 percent, respectively. Other gains included employment/productivity (20.6 percent), Medicaid (2.7 percent) and other insurers (7.8 percent). This means that for each cataract surgery on a single eye, which costs an average of $2,653, the savings will amount to $121,198. Additionally, the researchers found that over the 13-year model, cataract surgery yielded a 4,567 percent financial return on investment to society.

When compared to the estimated costs in previous study years, it was found that the overall cataract surgery cost in 2012 was 34.4 percent less expensive than in 2000 and 85 percent less expensive than in 1985 after adjusting for inflation. Furthermore, the inflation-adjusted physician fee in 2012 was only 10.1 percent of what it had been in 1985.

In terms of the patient value, the researchers found that cataract surgery yields an overall 36.2 percent gain in quality-of-life when performed in both eyes. Without cataract surgery, cataract-related vision loss can become so bad that individuals lose their independence in a variety of ways, such as being able to drive, read their mail, keep up their home and administer their medications.

"Most people regard healthcare costs, which are estimated by the Centers for Medicare and Medicaid at $2.81 trillion in 2012, as expenditures and not investment dollars that return patient value and financial value," said lead researcher Melissa M. Brown, M.D., of the Center for Value-Based Medicine and Wills Eye Hospital. "Our data demonstrates that this approach is far too simplistic and that estimating the return on investment provides a more complete picture. Cataract surgery is a paradigm for the premise that healthcare interventions, in addition to creating substantial patient value, can also create considerable economic wealth."

The study, The Extraordinary Patient Value and Financial Value to Society Conferred by Cataract Surgery (PA022) will be presented on Nov. 17 at the 117th Annual Meeting of the American Academy of Ophthalmology, which is in session November 16-19 at Ernest N. Morial Convention Center in New Orleans.


Story Source:

The above story is based on materials provided by American Academy of Ophthalmology (AAO). Note: Materials may be edited for content and length.


Journal Reference:

  1. Gary C. Brown, Melissa M. Brown, Alicia Menezes, Brandon G. Busbee, Heidi B. Lieske, Philip A. Lieske. Cataract Surgery Cost Utility Revisited in 2012. Ophthalmology, 2013; 120 (12): 2367 DOI: 10.1016/j.ophtha.2013.04.030

Cite This Page:

American Academy of Ophthalmology (AAO). "Cataract surgery saves $123.4 billion in costs, delivers 4,567% return to society." ScienceDaily. ScienceDaily, 15 November 2013. <www.sciencedaily.com/releases/2013/11/131115104553.htm>.
American Academy of Ophthalmology (AAO). (2013, November 15). Cataract surgery saves $123.4 billion in costs, delivers 4,567% return to society. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/11/131115104553.htm
American Academy of Ophthalmology (AAO). "Cataract surgery saves $123.4 billion in costs, delivers 4,567% return to society." ScienceDaily. www.sciencedaily.com/releases/2013/11/131115104553.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins